• OPEN AN ACCOUNT
Indian Indices
Sensex
77,966.35 -187.90
( -0.24%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,825.49 -18.70
(-0.17%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506197
INE416D01022
108.7340483
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BLISSGVS
53.62
5263.86
EPS(TTM)
Face Value()
Div & Yield %
9.24
1
0.2
 

shriram finance ltd
Voltas consolidated net profit declines 51.80% in the March 2026 quarter
May 15,2026
Net profit of Voltas declined 51.80% to Rs 116.18 crore in the quarter ended March 2026 as against Rs 241.02 crore during the previous quarter ended March 2025. Sales rose 2.44% to Rs 4843.54 crore in the quarter ended March 2026 as against Rs 4728.04 crore during the previous quarter ended March 2025.

For the full year,net profit declined 55.33% to Rs 375.88 crore in the year ended March 2026 as against Rs 841.37 crore during the previous year ended March 2025. Sales declined 7.82% to Rs 14122.99 crore in the year ended March 2026 as against Rs 15320.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4843.544728.04 2 14122.9915320.45 -8
OPM %3.816.36 -3.666.46 -
PBDT205.09357.22 -43 667.701252.53 -47
PBT184.50343.17 -46 583.601190.75 -51
NP116.18241.02 -52 375.88841.37 -55